Effects of new combinative antioxidant FeAOX-6 and α-tocotrienol on macrophage atherogenesis-related functions

Vascular Pharmacology

Volumn 46, Issue 6, 2007, Pages 394-405

  Napolitano, Mariarosaria ^a   Avanzi, Luca ^b   Manfredini, Stefano ^b   Bravo, Elena ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Tocotrienol; Arachidonic acid cascade; Cholesterol; FeAOX 6; Foam cell

Indexed keywords

ALPHA TOCOTRIENOL; ANTIOXIDANT; ARACHIDONIC ACID; CHOLESTEROL; FEAOX 6; PROSTAGLANDIN E2; RADICAL; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; ESTERIFICATION; FOAM CELL; HUMAN; HUMAN CELL; MACROPHAGE FUNCTION; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE;

ANTIOXIDANTS; ARACHIDONIC ACID; ATHEROSCLEROSIS; CELLS, CULTURED; CHOLESTEROL; CHOLESTEROL ESTERS; CHROMANS; CYTOKINES; DINOPROST; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FOAM CELLS; FREE RADICALS; HUMANS; INFLAMMATION; MACROPHAGES; RECEPTORS, SCAVENGER; VITAMIN E;

EID: 34047270734     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.01.019     Document Type: Article

References (52)

1. Amundson D.M., and Zhou M. Fluorometric method for the enzymatic determination of cholesterol. J. Biochem. Biophys. Methods 38 (1999) 43-52
2. Asmis R., and Jelk J. Vitamin E supplementation of human macrophages prevents neither foam cell formation nor increased susceptibility of foam cells to lysis by oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2078-2086
3. Balsinde J., Barbour S.E., Bianco I.D., and Dennis E.A. Arachidonic acid mobilization in P388D1 macrophages is controlled by two distinct Ca(2+)-dependent phospholipase A2 enzymes. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 11060-11064
4. Barrios-Rodiles M., Tiraloche G., and Chadee K. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1 beta and TNF-alpha. J. Immunol. 163 (1999) 963-969
5. Bradford M. A sensitive method for quantitation of microgram quantities of protein utilizing the principle of dye-binding. Anal. Biochem. 72 (1976) 248-252
6. Britton G. Structure and properties of carotenoids in relation to function. FASEB J. 9 (1995) 1551-1558
7. Brown M.S., Faust J.R., and Goldstein J.L. Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts. J. Clin. Invest. 55 (1975) 783-793
8. Brown M.S., and Goldstein J.L. Lipoprotein metabolism in the macrophages: implications for cholesterol deposition in atherosclerosis. Ann. Rev. Biochem. 52 (1983) 223-261
9. Cherubini A., Vigna G.B., Zuliani G., Ruggiero C., Senin U., and Fellin R. Role of antioxidants in atherosclerosis: epidemiological and clinical update. Curr. Pharm. Des. 11 (2005) 2017-2032
10. Chisolm G.M., and Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic. Biol. Med. 28 (2000) 1815-1826
11. Clarke R., and Armitage J. Antioxidant vitamins and risk of cardiovascular disease. Review of large scale randomised trials. Cardiovasc. Drugs Ther. 16 (2002) 411-415
12. de Lorgeril M. Mediterranean diet in the prevention of coronary heart disease. Nutrition 14 (1998) 55-57
13. Devaraj S., and Jialal I. Alpha-tocopherol decreases tumor necrosis factor-alpha mRNA and protein from activated human monocytes by inhibition of 5-lipoxygenase. Free Radic. Biol. Med. 38 (2005) 1212-1220
14. Douglas C.E., Chan A.C., and Choy P.C. Vitamin E inhibits platelet phospholipase A2. Biochem. Biophys. Acta 876 (1986) 639-645
15. Dugas T.R., Morel D.W., and Harrison E.H. Impact of LDL carotenoid and alpha-tocopherol content on LDL oxidation by endothelial cells in culture. J. Lipid Res. 39 (1998) 999-1007
16. Fox E.S., Brower J.S., Bellezzo J.M., and Leingang K.A. N-acetylcysteine and alpha-tocopherol reverse the inflammatory response in activated rat Kupffer cells. J. Immunol. 158 (1997) 5418-5423
17. Gey K.F. Optimum plasma levels of antioxidant micronutrients. Ten years of antioxidant hypothesis on arteriosclerosis. Bibl. Nutr. Dieta 51 (1994) 84-99
18. Hengartner U., Bernhard K., and Meyer K. Synthesis, isolation, and NMR-spectroscopic characterization of four teen (Z)-isomers of lycopene and some acetylenic didehydro- and tetrahydrolycopenes. Helv. Chim. Acta 75 (1992) 1848-1865
19. Hsu H.Y., Nicholson A.C., and Hajjar D.P. Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and post-transcriptionally regulated. J. Biol. Chem. 271 (1996) 7767-7773
20. Jiang Q., Elson-Schwab I., Courtemanche C., and Ames B.N. Gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11494-11499
21. Jung W.J., and Sung M.K. Effects of major dietary antioxidants on inflammatory markers of RAW 264.7 macrophages. Biofactors 21 (2004) 113-117
22. Kamat J.P., and Devasagayam T.P.A. Oxidative damage to mitochondria in normal and cancer tissues, and its modulation. Toxicology 155 (2000) 73-82
23. Kiemer A.K., Muller C., and Vollmar A.M. Inhibition of LPS-induced nitric oxide and TNF-alpha production by alpha-lipoicacid in rat Kupffer cells and in RAW 264.7 murine macrophages. Immunol. Cell Biol. 80 (2002) 550-557
24. Morrow J.D., Awad J.A., Kato T., Takahashi K., Badr K.F., Roberts II L.J., and Burk R.F. Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J. Clin. Invest. 90 (1992) 2502-2507
25. Munteanu A., Zingg J.M., and Azzi A. Anti-atherosclerotic effects of vitamin E-myth or reality?. J. Cell. Mol. Med. 8 (2004) 59-76
26. Napolitano M., and Bravo E. Activation of protein Kinase C by phorbol esters in human macrophages reduces the metabolism of modified LDL by down-regulation of scavenger receptor activity. Int. J. Biochem. Cell Biol. 35 (2003) 1127-1143
27. Napolitano M., and Bravo E. Lipid metabolism and TNF-alpha secretion in response to dietary sterols in human monocyte derived macrophages. Eur. J. Clin. Invest. 35 (2005) 482-490
28. Nathens A.B., Bitar R., Marshall J.C., Watson R.W., Dackiw A.P., Fan J., Hiscott J., and Rotstein O.D. Antioxidants increase lipopolysaccharide-stimulated TNF alpha release in murine macrophages: role for altered TNF alpha mRNA stability. Shock 16 (2001) 361-367
29. O'Leary K.A., de Pascual-Tereasa S., Needs P.W., Bao Y.P., O'Brien N.M., and Williamson G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat. Res. 551 (2004) 245-254
30. Palozza P., and Krinsky N.I. β-Carotene and α-tocopherol are synergistic antioxidants. Arch. Biochem. Biophys. 297 (1992) 184-187
31. Palozza P., Piccioni E., Avanzi L., Vertuani S., Calviello G., and Manfredini S. Design, synthesis, and antioxidant activity of FeAOX-6, a novel agent deriving from a molecular combination of the chromanyl and polyisoprenyl moieties. Free Radic. Biol. Med. 33 (2002) 1724-1735
32. Parker R.A., Pearce B.C., Clark R.W., Gordon D.A., and Wright J.J. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 268 (1993) 11230-11238
33. Pearce B.C., Parker R.A., Deason M.E., Qureshi A.A., and Wright J.J. Hypocholesterolemic activity of synthetic and natural tocotrienols. J. Med. Chem. 35 (1992) 3595-3606
34. Pratico D., and FitzGerald G.A. Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J. Biol. Chem. 271 (1996) 8919-8924
35. Qureshi A.A., Burger W.C., Peterson D.M., and Elson C.E. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J. Biol. Chem. 261 (1986) 10544-10550
36. Schneider C. Chemistry and biology of vitamin E. Mol. Nutr. Food Res. 49 (2005) 7-30
37. Serbinova E., Kagan V., Han D., and Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic. Biol. Med. 10 (1991) 263-275
38. Shige H., Ishikawa T., Suzukawa M., Nishiwaki M., Yamashita T., Nakajima K., Ito T., Higashi K., Ayaori M., Yonemura A., Nestel P., and Nakamura H. Vitamin E reduces cholesterol esterification and uptake of acetylated low density lipoprotein in macrophages. Lipids 33 (1998) 1169-1175
39. Skeen M.J., Miller M.A., Shinnick T.M., and Ziegler H.K. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J. Immunol. 156 (1996) 1196-1206
40. Stahl W., Heinrich U., Jungmann H., Sies H., and Tronnier H. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans. Am. J. Clin. Nutr. 71 (2000) 795-798
41. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat. Med. 8 (2002) 1211-1217
42. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Sakaguchi H., Kruijt J.K., Higashi T., Suzuki T., van Berkel T.J., Horiuchi S., Takahashi K., Yazaki Y., and Kodama T. The multiple roles of macrophage scavenger receptors (MSR) in vivo: resistance to atherosclerosis and susceptibility to infection in MSR knockout mice. J. Atheroscler. Thromb. 4 (1997) 1-11
43. Teupser J., Thiery D., and Seidel D. α-Tocopherol down-regulates scavenger receptor activity in macrophages. Atherosclerosis 144 (1999) 109-115
44. Theriault A., Chao J.T., Wang Q., Gapor A., and Adeli K. Tocotrienol: a review of its therapeutic potential. Clin. Biochem. 32 (1999) 309-319
45. Theriault A., Chao J.T., and Gapor A. Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes. Atherosclerosis 160 (2002) 21-30
46. Trach C.C., Wulfroth P.M., Severs N.J., and Robenek H. Influence of native and modified lipoproteins on migration of mouse peritoneal macrophages and the effect of the antioxidants vitamin E and probucol. Eur. J. Cell Biol. 71 (1996) 199-205
47. van Lenten B.J., and Fogelman A.M. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-alpha. J. Immunol. 148 (1992) 112-116
48. von der Thusen J.H., Kuiper J., van Berkel T.J., and Biessen E.A. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol. Rev. 55 (2003) 133-166
49. Wayner D.D., Burton G.W., Ingold K.U., and Locke S. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett. 18 (1985) 733-737
50. Witztum J.L. You are right too!. J. Clin. Invest. 115 (2005) 2072-2075
51. Wu D., Mura C., Beharka A.A., Han S.N., Paulson K.E., Hwang D., and Meydani S.N. Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am. J. Physiol. 275 (1998) C661-C668
52. Wu D., Liu L., Meydani M., and Meydani S.N. Vitamin E increases production of vasodilator prostanoids in human aortic endothelial cells through opposing effects on cyclooxygenase-2 and phospholipase A2. J. Nutr. 135 (2005) 1847-1853